News

• Johnson & Johnson added 0.1% to $157.57 after the company reported slightly better-than-expected quarterly results. 
  
  Revenue in the third quarter increased 6.8% to $21.3 billion from $19.99 billion and net earnings was flat at $4.3 billion and diluted earnings per share edged up 4% to $1.69 from $1.62 a year ago. 
  
  Sales in the U.S. increased 11.1% to $12 billion from $10.8 billion and international sales rose 1.6% to $9.3 billion from $9.2 billion a year ago. 
  
  The company revised higher its estimate of non-GAAP annual sales growth estima More
  
  Oct 17, 2023
• Johnson & Johnson added 0.1% to $157.57 after the company reported slightly better-than-expected quarterly results. 
  
  Revenue in the third quarter increased 6.8% to $21.3 billion from $19.99 billion and net earnings was flat at $4.3 billion and diluted earnings per share edged up 4% to $1.69 from $1.62 a year ago. 
  
  Sales in the U.S. increased 11.1% to $12 billion from $10.8 billion and international sales rose 1.6% to $9.3 billion from $9.2 billion a year ago. 
  
  The company revised higher its estimate of non-GAAP annual sales growth estimate to between 8.5% and 9.0% from the previous estimate between 8.0% and 8.5%.    Less
  
  Oct 17, 2023


• Johnson & Johnson the pharmaceuticals and consumer products maker, said first quarter revenue increased 5.6% to $24.75 billion. 
  
  The company swung to a net loss of $68 million from a profit of $5.2 billion and diluted earnings per share swung to ($0.03) from $1.93 a year ago. 
  
  Adjusted earnings, which excludes special items and amortization expenses,  fell 0.9% to $7.06 billion from $7.2 billion and adjusted diluted earnings per share inched up to $2.68 from $2.67 a year ago. 
  
  Apr 18, 2023
• Johnson & Johnson the pharmaceuticals and consumer products maker, said first quarter revenue increased 5.6% to $24.75 billion. 
  
  The company swung to a net loss of $68 million from a profit of $5.2 billion and diluted earnings per share swung to ($0.03) from $1.93 a year ago. 
  
  Adjusted earnings, which excludes special items and amortization expenses,  fell 0.9% to $7.06 billion from $7.2 billion and adjusted diluted earnings per share inched up to $2.68 from $2.67 a year ago.  Less
  
  Apr 18, 2023

Executive/
Director

Links

YTD

Earnings

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Outstanding Shares
(In Millions) +

Financial Statements
+

SEC Filings

Financial Ratios